AU3743997A - A novel method of detecting and treating cancer - Google Patents

A novel method of detecting and treating cancer

Info

Publication number
AU3743997A
AU3743997A AU37439/97A AU3743997A AU3743997A AU 3743997 A AU3743997 A AU 3743997A AU 37439/97 A AU37439/97 A AU 37439/97A AU 3743997 A AU3743997 A AU 3743997A AU 3743997 A AU3743997 A AU 3743997A
Authority
AU
Australia
Prior art keywords
detecting
treating cancer
novel method
novel
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU37439/97A
Other languages
English (en)
Inventor
Carl J. Schmidt
Frank L. Tobin
Francis E. Wilkinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/714,744 external-priority patent/US5747264A/en
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU3743997A publication Critical patent/AU3743997A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • G01N2333/918—Carboxylic ester hydrolases (3.1.1)
    • G01N2333/92—Triglyceride splitting, e.g. by means of lipase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU37439/97A 1996-08-02 1997-07-31 A novel method of detecting and treating cancer Abandoned AU3743997A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US69147996A 1996-08-02 1996-08-02
US08691479 1996-08-02
US08/714,744 US5747264A (en) 1996-08-02 1996-09-16 Method of diagnosing and monitoring prostate cancer
US08714744 1996-09-16
PCT/US1997/013550 WO1998005349A1 (en) 1996-08-02 1997-07-31 A novel method of detecting and treating cancer

Publications (1)

Publication Number Publication Date
AU3743997A true AU3743997A (en) 1998-02-25

Family

ID=27104791

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37439/97A Abandoned AU3743997A (en) 1996-08-02 1997-07-31 A novel method of detecting and treating cancer

Country Status (5)

Country Link
EP (1) EP0918532A4 (de)
JP (1) JP2001500847A (de)
AU (1) AU3743997A (de)
CA (1) CA2262624A1 (de)
WO (1) WO1998005349A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2320843A1 (en) * 1998-02-23 1999-08-26 Diadexus, Llc Methods using pla2 as a marker of metastases and for the diagnosis of selected cancers
IL131887A0 (en) * 1999-09-14 2001-03-19 Dpharm Ltd Phospholipid prodrugs of anti-proliferative drugs
AUPS282602A0 (en) 2002-06-07 2002-06-27 Garvan Institute Of Medical Research Method of inhibiting cell proliferation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994000766A1 (en) * 1992-06-23 1994-01-06 Auckland Uniservices Limited Gravidin: assays, dna fragments or genes and uses thereof

Also Published As

Publication number Publication date
JP2001500847A (ja) 2001-01-23
EP0918532A1 (de) 1999-06-02
WO1998005349A1 (en) 1998-02-12
EP0918532A4 (de) 2001-01-03
CA2262624A1 (en) 1998-02-12

Similar Documents

Publication Publication Date Title
EP0906099A4 (de) Verfahren zur behandlung von krebs
EP0730245A3 (de) Digitalisiergerät und Verfahren zur Positionsdetektierung
AU3982797A (en) Program guide system and method of operation
EP0973396A4 (de) Verfahren zur behandlung von krebs
GB9801231D0 (en) A method of treating cancer
GB2311192B (en) Data-transmitter-receiver and method of operation
AU4003597A (en) Methods of diagnosing and treating cancer
AU2417997A (en) A demining machine and a method of demining
ZA976814B (en) A novel method of detecting and treating cancer.
AU3743997A (en) A novel method of detecting and treating cancer
AU5369498A (en) Compounds and methods for treating cancer
AU4027097A (en) Method of treatment
AU2769497A (en) Therapy apparatus and method
EP0987943A4 (de) Verfahren zum nachweis und zur behandlung von krebs
AU6256499A (en) A method of treating cancer
AU5354296A (en) Slot machine and methods of operation
AUPO439396A0 (en) A method of treatment and prophylaxis
EP1019529A4 (de) Verfahren zur krebsbehandlung
AU3149297A (en) Methods of treating hypertension
GB9613599D0 (en) A method of treating cancer
GB9612913D0 (en) A method of treating cancer
GB9611982D0 (en) A method of treating cancer
AU3488295A (en) Method of treating malignant conditions
AU6162499A (en) A method of treating cancer
AUPO210896A0 (en) Methods of diagnosing and treating cancer